Transcript Advanced Oncology Pharmacy Practice

Higher Level Practitioner
Development: A Way Forward
in the South East
BOPA Symposium 2007
Michael Powell
Lead Pharmacist
Mount Vernon Cancer Network
Aims
• To outline the function of the Joint
Programme Board
• To describe the pharmacy practitioner
development strategy as it relates to
higher level practice
• To describe current and likely future
developments in higher level practice in the
South East. How might these be relevant
to oncology pharmacy practice?
Why reform post-registration education?
• No systematic provision of post grad
education for pharmacy practitioners.
• Level of current provision evolved in
somewhat haphazard way from the
need for a level of clinical pharmacist
skills and knowledge not catered for
by undergrad/pre-reg curricula
Why reform post-registration education?
• Foster Report (July 2006):
– Re-emphasises the need for competence
linked with performance assessment
– Emphasises the need for re-validation:
• Ongoing evaluation of an individual’s fitness
to practice
• Must be both formative and summative
Department of Health. The regulation of the non-medical healthcare professions. A review by
the Department of Health. July 2006.
The Joint Programme Board
(JPB):
Membership and Function
What is the JPB?
Educational Quality
NHS
Specialist Services
Specialist groups
Senior Managers
Collaboration
Service Perspective
Academia (SOPs)
Brighton
KCL
Medway
Portsmouth
London
UEA
Key JPB Responsibilities
•
•
•
•
•
•
•
Develop uniform & coherent curricula for
general and advanced practice
Develop tutor training courses to support workbased learning
Design reliable, fair & appropriate assessments
Undertake the accreditation of training centres
Build systems for on-going QA of E&T systems
Assign academic credits to programmes as
appropriate
Issue statements of completion of training at
general & advanced levels.
To Date – Generalist Training Band
6 (3 years)
• PG Diploma in General Pharmacy Practice (MI,
Technical, Patient & Clinical Services plus
“tasters” of specialist areas)
• Validated by 5 of the JPB HEI’s
• Statement of completion of general training
• Currently 200 practitioners/students across the
south-east
JPB as a supportive infrastructure
The NHS
SPMs,
HEIs
Training Centres,
Specialist Pharmacy
Services
Post-Registration
Pharmacy
Joint Programmes Board
The NHS
Pharmacy
SIGs
?
Training
Centres
(Gen + Specialist)
Directors Pharmacy
Education
(Trust/Pan-Trust
Roles)
Developing the infrastructure –
key principles
• Work-based learning
• Resources practice tutors
• Assesses competence and performance
• Systems for dealing with poor performance
• Standardises approaches across specialties
PG enabling programmes
General Diploma
Training infrastructure support
Undergraduate &
Pre-registration
Phases
General Level
Development
Phase
Masters Adv Practice
Research Degree
Higher Level Practice System
Higher Level
Development
Phase 1
Higher Level
Development
Phase 2
Consultant
Practitioner
Advanced
Practitioner
General
Level
Practitioner
General
Level
Framework
Higher Level
Framework: Advanced &
Consultant
JPB
(Regional e.g. South East England)
Training Centres
•Single Trusts or collaboratives – across health sectors
•Accredited to deliver training at Generalist, Higher Level or both
•Internal QA systems
•Manage tutee experiences
Higher Level Practice
The Career Pathway
Practitioner Development Strategy
• Imperative to recognise formally that
there are different levels of
practice:
– complex & diverse nature of pharmacist
roles
– Clinical governance
– Impact of AfC
D Webb et al. Hosp Pharm Mar 2004; 11: 104-109
Practitioner Development Strategy
• Different levels of practice must capture:
– Clinical pharmacy specialisation (e.g. oncology)
– Expertise in other disciplines (e.g. MI, tech
services)
• Should be sector independent:
– Should encompass pharmacy practitioners
within 1°/2° care and community pharmacy
D Webb et al. Hosp Pharm Mar 2004; 11: 104-109
JPB & Higher Level Practice
• Focus now on developing strategy for
higher level practitioner development
• Scoping meetings held in London in January
and May 2007
• Key themes:
–
–
–
–
–
–
–
–
–
Consistency
Overcoming silo mentality
Identifying barriers
Overcoming barriers
System of representation
Collaborations with HEIs
Time frames
Duality of award
Titles
Practitioner development strategy:
Alignment with AfC
Band 7 – 8a
(3-5yrs)
Band 6
(3yrs)
Undergraduate &
Pre-registration
Phases
General Level
Development
Phase
Higher Level
Development
Phase 1
Band 8 b-d
(3 yrs)
Higher Level
Development
Phase 2
Consultant
Practitioner
Advanced
Practitioner
General
Level
Practitioner
General
Level
Framework
Higher Level
Framework: Advanced &
Consultant
Higher Level Practice
Using the ACLF as the backbone
Advanced & Consultant Level Framework
(ACLF)
• 34 competencies in 6 clusters:
–
–
–
–
–
–
Expert professional practice (EPP)
Building working relationships (BR)
Leadership (L)
Management (M)
Education, training & development (ETD)
Research & evaluation (RE)
• Each competency has 3 levels of
attainment: Foundation, excellence &
mastery
• In England, describes the competency
profiles expected of applicants for
consultant pharmacist posts
Competency Profiles
• Consultant profile
– EPP, BR and L at
Mastery
– M, ETD and RE at
Excellence
• Advanced profile
– 5 clusters at Excellence
– RE at Foundation
• PhwSI profile
– 4 clusters at Excellence
– 2 clusters ETD, RE
optional
JPB – some key facts
• JPB does not influence Specialist Group alliances or
relationships
• JPB is a system for discharging the curriculum –
which belongs to the specialist group
• JPB is an inclusive system – engages all SGs and all
HEIs – promotes local relationships rather than
aligning with one HEI.
• Research commitment to final aspect (8b-d) requires
local HEI engagement
• Encourages all SGs to collaborate to standardise the
output across specialities
• JPBs must maintain a geographical relationship which
builds on existing and historical networks.
Accreditation
• Clear recognition that JPB should work
with specialist groups such as BOPA to:
– Design the curricula for general & advanced
level practice
– Design appropriate assessment methods to
meet the learning outcomes associated with
general & advanced practice
• Assessment of portfolio of evidence
• Viva
Latest Developments with
the JPB
Dr Catherine Duggan
Associate Director of Clinical Pharmacy for Evaluation and Development &
Senior Clinical Lecturer
London, Eastern and South East NHS and School of Pharmacy,
University of London
Further reading
• Key literature on practitioner development:
– Davies et al. Hosp Pharm Jan 04; 11: 2
– Webb et al. Hosp Pharm Mar 04; 11: 104-109
– Bates et al. Pharm J Mar 04; 272: 283
• Websites for further info:
– JPB: www.postgraduatepharmacy.org
– CoDEG: www.codeg.org